TruthArchive.ai - Related Video Feed

Video Saved From X

reSee.it Video Transcript AI Summary

The speaker's administration will implement "most favored nations" drug pricing, ensuring Americans pay the lowest price for drugs compared to other developed countries. Some prescription drug prices will be reduced almost immediately by 50% to 90%. Big Pharma must voluntarily comply or the federal government will ensure equal pricing. To accelerate price reductions, the administration will cut out the middlemen to facilitate direct drug sales to American citizens at the most favored nation price. The speaker believes the middlemen are worse than drug companies because they don't make a product but make a fortune.

Video Saved From X

reSee.it Video Transcript AI Summary

Have you faced pressure not to work with RFK Junior? Yes, I have. Big Pharma is not pleased with my collaboration. Despite their mixed responses, I've always had a good relationship with him. He’s intelligent and genuinely sincere about his views. He believes we spend excessively on pesticides, and when comparing our spending to other countries that invest little, the results are concerning. There’s potential for significant savings. However, some people are not happy with my association with him.

Video Saved From X

reSee.it Video Transcript AI Summary

The speaker states they decided to break the system, referring to drug companies, which they describe as the most powerful lobby in the world. They claim drug companies have tremendous power over the Senate, the House, governors, and everybody. The speaker notes that drug companies spend billions of dollars. Despite this, the speaker says they don't care and must do what's right.

Video Saved From X

reSee.it Video Transcript AI Summary

Former President Trump claims that he was the only president to take on big pharma, but Joe Biden canceled his toughened pharmaceutical policies. Trump signed an executive order to ensure that the US government pays the same price for pharmaceuticals as other countries, saving American patients billions of dollars. However, Biden reversed this order, allowing other countries to negotiate lower prices while Americans pay high prices. Trump promises that if he is reelected, he will sign an executive order to end this unfair practice and make Big Pharma lower prices for American patients. He believes that rescinding his original order shows the power of Big Pharma, but he is determined to deliver savings for seniors and all American patients.

Video Saved From X

reSee.it Video Transcript AI Summary

I am implementing a rebate that cuts out the middlemen in the drug industry, reducing costs and benefiting the people purchasing the drugs. Despite facing opposition from wealthy individuals, I believe this is our only opportunity to make a change. No other president would take the steps I am taking, such as implementing favored nations and buying from other countries at lower prices. These actions have made a lot of rich people unhappy, but I am determined to prioritize the well-being of the people over their profits.

Video Saved From X

reSee.it Video Transcript AI Summary

The administration will secure "most favored nations" drug pricing, meaning Americans will pay the lowest price for drugs paid in other developed countries. Some prescription drug prices will be reduced almost immediately by 50 to 90%. Big Pharma will either abide by this principle voluntarily, or the federal government will ensure Americans pay the same price as other countries. To accelerate price reductions, the administration will cut out the middlemen and facilitate the direct sale of drugs at the most favored nation price directly to American citizens. The middlemen are considered worse than the drug companies because they don't make a product but make a fortune.

Video Saved From X

reSee.it Video Transcript AI Summary

Under Biden, there has been a significant increase in shortages of essential medicines, with a 30% rise in new drug shortages last year alone. Currently, there is a shortage of at least 14 critical cancer drugs in the US. Delaying cancer treatment by a month increases the risk of death by 10%. It's shocking that this is happening in the US in 2023. China is the top producer of critical medicines, supplying 95% of Ibuprofen, 91% of Hydrocortisone, 70% of Tylenol, and almost half of all penicillin. This poses a national security crisis, not just a public health crisis. To achieve independence from China, I will implement tariffs and import restrictions to bring back production of essential medicines to the US, creating new American jobs.

Video Saved From X

reSee.it Video Transcript AI Summary

You don't want RK Jr suing big pharma, right? Check my website; I don’t accept contributions from big pharma executives or corporate PAC money. You and your allies are already aware of this.

Video Saved From X

reSee.it Video Transcript AI Summary

I aim to eliminate middlemen and reduce costs in the pharmaceutical industry, allowing the money saved to benefit drug purchasers. Unlike drug companies, who produce tangible products, these middlemen do not contribute in the same way. My enemies, who are wealthy individuals, are displeased with my actions. However, I believe this is our only opportunity to make a change, as no other president would take such steps. This may be my last appearance for a while.

Video Saved From X

reSee.it Video Transcript AI Summary

Politicians have long promised to eliminate the discrepancy between drug prices in the U.S. and Europe. This was a key issue for Bernie Sanders, but previous leaders haven't acted on it. Politicians make these promises knowing they likely won't have to fulfill them. The reason is that Congress is heavily influenced by the pharmaceutical industry. There is at least one pharmaceutical lobbyist for every congressman, senator, and Supreme Court member.

Video Saved From X

reSee.it Video Transcript AI Summary

Robert F. Kennedy Jr. praises President Trump for addressing the discrepancy between US and European drug prices, a promise unfulfilled by previous Democratic leaders due to pharmaceutical industry influence. Kennedy claims there is at least one pharmaceutical lobbyist for every congressman, senator, and Supreme Court member, and the industry spends three times more on lobbying than any other. Kennedy states that Trump cannot be bought and is standing up to oligarchs, unlike other politicians. He notes that the US, with 4.2% of the world's population, accounts for 75% of pharmaceutical company revenues, spending $11.26 per capita on drugs compared to Britain's $240. Kennedy says Trump is asking European partners to increase their drug payments to fund innovation, suggesting a 20% increase would free up $10 trillion for innovation and improve global health.

Video Saved From X

reSee.it Video Transcript AI Summary

We're paying too much for drugs compared to other countries, and existing laws make it hard to lower costs. The middlemen in the drug industry are profiting significantly without adding value. We're going to eliminate these middlemen to reduce drug prices to unprecedented levels. This topic dominated our discussions with executives and others involved.

Video Saved From X

reSee.it Video Transcript AI Summary

The speaker states they decided to break the system, referring to drug companies, which they describe as the most powerful lobby in the world with tremendous power over the Senate, the House, governors, and everybody. The speaker notes that drug companies spend billions of dollars. The speaker claims they don't care and have to do what's right.

Video Saved From X

reSee.it Video Transcript AI Summary

We are working to ensure fair pricing for drugs developed with taxpayer money. If drug companies set high prices that Americans can't afford, the government can allow other companies to produce and sell the same drug at a lower cost. This promotes competition, lowers costs, raises wages, and improves care. We are also cracking down on anti-competitive practices in healthcare, including junk health insurance plans.

Video Saved From X

reSee.it Video Transcript AI Summary

I don't accept contributions from big pharma executives or corporate PAC money. You and your allies are aware of this.

Video Saved From X

reSee.it Video Transcript AI Summary

Almost all panel members, including you, are accepting significant contributions from the pharmaceutical industry. I ran for president too and received substantial contributions, but they did not come from executives. Out of 200 million, I received 1.5 million. You still haven't answered my last question.

Video Saved From X

reSee.it Video Transcript AI Summary

I'm committed to making America healthier than other countries. Will you guarantee the same healthcare coverage that other major countries provide? Corruption isn't just in federal agencies; it's in Congress too. Many members here, including you, accept millions from the pharmaceutical industry to protect their interests. I ran for president and received millions in contributions, but none came from pharmaceutical executives or PACs. My support comes from workers, not corporate interests. You were the largest recipient of pharmaceutical donations in 2020. No, I received support from workers across the country, not from corporations. You still haven't answered the last question.

Video Saved From X

reSee.it Video Transcript AI Summary

I never thought my political opponent would be indicted, but it happened while my popularity grew. I didn't take a salary and worked hard for this country. However, this sets a dangerous precedent for the future, as it could easily happen to them. Crooked Joe and his thugs are trying hard to stop me because I caused major disruption in my first term. Now, in my second term, I don't want the same results.

Video Saved From X

reSee.it Video Transcript AI Summary

Politicians have long promised to address the discrepancy between drug prices in the U.S. and Europe. This issue was central to Bernie Sanders' presidential campaigns. However, these promises were never fulfilled because Congress is heavily influenced by the pharmaceutical industry. There is at least one pharmaceutical lobbyist for every member of Congress, the Senate, and the Supreme Court.

Video Saved From X

reSee.it Video Transcript AI Summary

As a presidential candidate, the speaker plans to set drug prices based on fair market value, charging American consumers the average global price for drugs. For example, insulin prices would be impacted. If companies don't cooperate, the speaker intends to address drugs developed with federal funding. For any drug that benefited from taxpayer-funded research and development, and where companies fail to comply with pricing rules, the speaker will seize their patent. The speaker asserts this action is permissible and expresses the determination to execute it.

Video Saved From X

reSee.it Video Transcript AI Summary

Former President claims to have taken on big pharma with tough policies, but accuses President Biden of canceling them. He signed an executive order to ensure the US government pays the same price for pharmaceuticals as other countries. However, Biden rescinded this order, allegedly betraying patients and seniors. The US has been paying high prices for drugs while other countries negotiate lower prices. The former President promises to end this by signing an executive order that will only pay the best price offered to foreign nations. This will supposedly force big pharma to raise prices for other countries and reduce prices for American patients, resulting in significant savings.

Video Saved From X

reSee.it Video Transcript AI Summary

Americans pay significantly more for prescription drugs than other countries, sometimes up to 10 times more. Pharmaceutical companies generate two-thirds of their profits in the U.S., effectively making Americans subsidize healthcare in other countries. The administration is introducing a "most favored nation" pricing model, ensuring the U.S. pays the lowest price available globally for drugs. For example, a breast cancer drug costing over $16,000 in the U.S. is a fraction of that price in Australia and Sweden. Similarly, an asthma drug costs almost $500 in the U.S. but less than $40 in the UK. The plan involves directing investigations into foreign nations that block drug products unless they accept low prices, and the U.S. will defend drug companies from unfair pricing demands. The administration aims to cut out middlemen and facilitate direct drug sales at the most favored nation price. If companies don't comply, the U.S. will use its trade powers and open the market to safe, legal drug imports.

Video Saved From X

reSee.it Video Transcript AI Summary

Pharmaceutical companies spend three times more on lobbying than the next largest lobbyist. This issue was considered radioactive, but President Trump addressed it despite past contributions from pharmaceutical companies, which may have totaled $100,000,000. Unlike other politicians, Trump cannot be bought and is standing up for the American people. Despite claims from figures like Elizabeth Warren and Robert Reich that President Trump is on the side of the oligarchs, no president has been more willing to stand up to them than President Donald Trump. The speaker expressed pride in the President's courage and willingness to stand up for the American people.

Video Saved From X

reSee.it Video Transcript AI Summary

Pharmaceutical companies spend three times more on lobbying than the next largest lobbyist. While many discussed the issue, nobody acted due to its controversial nature. President Trump, described as a man of his word, is willing to stand up to the oligarchs, unlike most politicians who can be bought. Despite allegedly receiving $100,000,000 from the pharmaceutical industry, Trump cannot be bought. The speaker praises President Trump for his courage and willingness to stand up for the American people.

The Megyn Kelly Show

Trump Takes On Big Pharma with Drugs Exec Order, and Michelle Obama's Bitterness, with Walter Kirn

Guests: Walter Kirn

reSee.it Podcast Summary

Megyn Kelly opens the show by discussing significant recent developments involving President Trump, including a groundbreaking executive order on prescription drug prices and a temporary pause on tariffs with China. She highlights the economic implications of these moves, noting that experts believe the trade war with China was unsustainable for the U.S. economy. Kelly emphasizes that both Trump and Bernie Sanders share a common goal of allowing the government to negotiate drug prices, a topic that has historically faced resistance from big pharma. Kelly explains that Trump's new executive order aims to negotiate prices for all drugs, not just those under Medicare, and could potentially save Americans up to 80% on their prescriptions. She contrasts this with previous attempts by Trump and Biden, noting that the pharmaceutical industry has historically resisted such negotiations. Walter Kirn joins the discussion, agreeing that the drug pricing issue transcends party lines and is a matter of public interest. The conversation shifts to the implications of Trump's executive order, with Kirn suggesting that it could unite unlikely political allies against the powerful pharmaceutical lobby. They discuss the historical context of drug pricing in the U.S. compared to other countries, where Americans often pay significantly more for the same medications. Kelly and Kirn express skepticism about how Democrats will respond to Trump's initiative, given their past support for similar measures. The discussion then moves to Trump's recent dealings with China, where both countries have agreed to reduce tariffs temporarily while negotiating a more comprehensive trade agreement. Kelly cites market reactions and expert opinions indicating that this pause was necessary to prevent economic downturns, particularly for small businesses reliant on Chinese imports. Later, Kelly touches on a controversial incident involving the Democratic mayor of Newark and members of Congress confronting ICE officials, which escalated into a physical altercation. She criticizes the lawmakers for their aggressive behavior and suggests that such confrontations are becoming a tactic for Democrats to illustrate social issues. The show concludes with a critique of Michelle Obama’s recent comments about marriage and her public persona, with Kelly arguing that Obama’s narrative reflects a broader cultural trend of victimhood and dissatisfaction. The hosts express concern over the implications of such narratives on societal expectations and personal accountability.